Related Experiment Video
Updated: Jun 15, 2026

09:07
Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Mast cells and mastocytosis
1Colorectal Surgery Unit, Department of Surgery, University Hospital, Linköping, Sweden. johan.d.soderholm@liu.se
Digestive Diseases (Basel, Switzerland)
|March 6, 2010
Summary
Mast cells (MCs) are crucial for gut defense, releasing mediators that impact gastrointestinal functions. Dysregulation of these cells contributes to diseases like systemic mastocytosis and irritable bowel syndrome.
Area of Science:
- Gastroenterology and Immunology
Background:
- Mast cells (MCs) are immune cells located at body barrier sites, particularly the intestinal mucosa.
- MCs release diverse bioactive mediators, including histamine, tryptase, prostaglandins, leukotrienes, and cytokines, crucial for innate host defense.
- A significant bidirectional communication exists between MCs and enteric nerves, regulating gastrointestinal (GI) functions.
Purpose of the Study:
- To explore the multifaceted roles of mast cells in gastrointestinal health and disease.
- To understand the implications of mast cell mediator release and infiltration in conditions such as systemic mastocytosis and functional GI disorders.
- To highlight the involvement of mast cells in neuroimmune interactions within the GI tract.
Main Methods:
- Review of existing literature on mast cell biology and their involvement in GI pathophysiology.
- Analysis of diagnostic approaches for mast cell-related disorders, including endoscopy, biopsies, bone marrow biopsy, and serum tryptase levels.
- Examination of therapeutic strategies for mast cell-related conditions, ranging from symptomatic treatment to cytoreductive therapy.
Main Results:
- Gain-of-function mutations in c-kit are linked to systemic mastocytosis, characterized by GI symptoms like abdominal pain and diarrhea due to MC mediator release or infiltration.
- MCs play a key role in neuroimmune interactions, influencing stress responses, mucosal function in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), and non-erosive reflux disease.
- Diagnostic tools confirm MC infiltration and mediator activity, guiding treatment decisions.
Conclusions:
- Mast cells possess vital regulatory and protective roles in innate immunity within the GI tract.
- Dysfunctional mast cell activity can mediate mucosal pathophysiology, contributing to various GI diseases.
- Further research is needed to effectively manage and balance mast cell responses for therapeutic benefit.
Related Concept Videos
Inflammation
Overview
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

